Bristol-Myers Squibb and ANI Pharmaceuticals are both companies operating within the pharmaceuticals segment.
4 reports, 1 independent
Updated Aug 6
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bristol-Myers Squibb and ANI Pharmaceuticals are both companies operating within the pharmaceuticals segment.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Bristol-Myers Squibb and ANI Pharmaceuticals are companies in the pharmaceuticals segment.1 source
Bristol-Myers Squibb, Amneal Pharmaceuticals, and Merck were noted on August 4, 2025, as companies operating within the pharmaceuticals segment.1 source
Keep exploring
The entities involved
-
Bristol-Myers Squibb
American pharmaceutical company
-
ANI Pharmaceuticals (United States)
company in Baudette, United States
Nothing else this week.
-
Merck
public company in Indonesia
Related events
- Bristol-Myers Squibb and AbbVie secured regulatory approval for a therapy in the US.
- AbbVie, Johnson & Johnson, Bristol-Myers Squibb, and Amgen are innovating targeted, cost-effective therapies for psoriatic arthritis.
- Companies are pouring billions into protein degraders, a drug class that has received FDA approval and is being discussed by ASCO.
- Canadian investors can access U.S. companies, including Bristol-Myers Squibb, via Canadian Deposit Receipts (CDRs).
- AbbVie, Eli Lilly, and Merck are broadening their therapeutic reach.
Coverage
Newest first; wire copies grouped- StockStoryANI Pharmaceuticals (ANIP) Q2 Earnings: What To Expect Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) will be reporting earnings this Friday before the bell. Here’s what to look f
- StockStoryAmneal Earnings: What To Look For From AMRX Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) will be reporting earnings this Tuesday before the bell. Here’s what investors should know. Amn